SOMNUS MEDICAL TECHNOLOGIES INC risk profile
43 Elevated one input has moved against it
Measured 1 September 2026 from SOMN's filed statements. Recomputed nightly.
43 (Elevated), driven by Cash conversion at 64, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 21 | Normal | Stable | One-year price volatility — 14.3% |
| Operating pressure | 51 | Elevated | Worsening | Costs outgrowing revenue — +2.7 percentage points |
| Cash conversion | 64 | Stretched | Worsening | Capital spending against operating cash — 1.30x |
| Leverage and coverage | 30 | Normal | Stable | Current ratio — 0.65x |
| Competitive position | 42 | Elevated | Stable | Revenue-growth gap against peers — -6.8 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Utilities companies with a risk reading
NextEra Energy Inc 39Iberdrola S.A. 40Enel SpA 49Southern Company 47Constellation Energy Corporation 47Duke Energy Corp 46National Grid PLC 51National Grid Plc 49Engie S.A. 63American Electric Power Company Inc 43Dominion Energy Inc 41Sempra 48
Financials, valuation and price history for SOMNUS MEDICAL TECHNOLOGIES INC